These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 26889984

  • 1. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
    Al-Amri AM, Vatte C, Cyrus C, Chathoth S, Hashim TM, Mohamed YS, Al Ali R, Alsaid A, Al Ali A.
    Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
    [Abstract] [Full Text] [Related]

  • 2. PIK3CA mutations in head and neck squamous cell carcinoma.
    Qiu W, Schönleben F, Li X, Ho DJ, Close LG, Manolidis S, Bennett BP, Su GH.
    Clin Cancer Res; 2006 Mar 01; 12(5):1441-6. PubMed ID: 16533766
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC.
    Ekizoglu S, Dogan S, Ulker D, Seven D, Gozen ED, Karaman E, Buyru N.
    Clin Otolaryngol; 2015 Dec 01; 40(6):622-8. PubMed ID: 25850957
    [Abstract] [Full Text] [Related]

  • 5. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
    Suda T, Hama T, Kondo S, Yuza Y, Yoshikawa M, Urashima M, Kato T, Moriyama H.
    BMC Cancer; 2012 Sep 20; 12():416. PubMed ID: 22994622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG, Li YY, Jo VY, Rabinowits G, Lorch JH, Tishler RB, Margalit DN, Schoenfeld JD, Annino DJ, Goguen LA, Thomas T, Becker H, Haddad T, Krane JF, Lindeman NI, Shapiro GI, Haddad RI, Hammerman PS.
    Clin Cancer Res; 2016 Jun 15; 22(12):2939-49. PubMed ID: 26763254
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma.
    McBride SM, Rothenberg SM, Faquin WC, Chan AW, Clark JR, Ellisen LW, Wirth LJ.
    Head Neck; 2014 Aug 15; 36(8):1181-8. PubMed ID: 23852799
    [Abstract] [Full Text] [Related]

  • 11. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.
    Baba Y, Maeda T, Suzuki A, Takada S, Fujii M, Kato Y.
    Int J Mol Sci; 2017 Jan 26; 18(2):. PubMed ID: 28134774
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities.
    Kondo N, Tsukuda M, Taguchi T, Nakazaki K, Sakakibara A, Takahashi H, Toth G, Nishimura G.
    Cancer Sci; 2011 Sep 26; 102(9):1717-23. PubMed ID: 21631644
    [Abstract] [Full Text] [Related]

  • 15. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, Ferris RL, Carey TE, Myers JN, Pickering CR, Head and Neck Cancer Specialized Program of Research Excellence (SPORE) Human Immunodeficiency Virus (HIV) Supplement Consortium.
    Cancer; 2018 Jan 01; 124(1):84-94. PubMed ID: 29053175
    [Abstract] [Full Text] [Related]

  • 16. The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
    Martin D, Abba MC, Molinolo AA, Vitale-Cross L, Wang Z, Zaida M, Delic NC, Samuels Y, Lyons JG, Gutkind JS.
    Oncotarget; 2014 Oct 15; 5(19):8906-23. PubMed ID: 25275298
    [Abstract] [Full Text] [Related]

  • 17. Molecular profiling of head and neck squamous cell carcinoma.
    Feldman R, Gatalica Z, Knezetic J, Reddy S, Nathan CA, Javadi N, Teknos T.
    Head Neck; 2016 Apr 15; 38 Suppl 1(Suppl 1):E1625-38. PubMed ID: 26614708
    [Abstract] [Full Text] [Related]

  • 18. Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma.
    Pedrero JM, Carracedo DG, Pinto CM, Zapatero AH, Rodrigo JP, Nieto CS, Gonzalez MV.
    Int J Cancer; 2005 Mar 20; 114(2):242-8. PubMed ID: 15543611
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling.
    Du L, Chen X, Cao Y, Lu L, Zhang F, Bornstein S, Li Y, Owens P, Malkoski S, Said S, Jin F, Kulesz-Martin M, Gross N, Wang XJ, Lu SL.
    Oncogene; 2016 Sep 01; 35(35):4641-52. PubMed ID: 26876212
    [Abstract] [Full Text] [Related]

  • 20. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I, Budach V, Saki M, Konschak R, Niehr F, Jöhrens K, Weichert W, Linge A, Lohaus F, Krause M, Neumann K, Endris V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Baumann M, DKTK-ROG.
    Eur J Cancer; 2016 Apr 01; 57():78-86. PubMed ID: 26896955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.